Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
Abstract Vaginal and vulvar squamous cell carcinoma (SCC) are rare tumors that can be challenging to treat in the recurrent or metastatic setting. We present a case series of patients with vaginal or vulvar SCC who were treated with single-agent pembrolizumab as part of a phase II basket clinical tr...
Main Authors: | Jeffrey A. How, Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha-Paul, Filip Janku, Bettzy Stephen, Aung Naing |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83317-7 |
Similar Items
-
Vulvar and vaginal tumors in Hawshar dogs
by: B.T. Abbas, et al.
Published: (2018-06-01) -
382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study
by: Filip Janku, et al.
Published: (2020-11-01) -
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
by: Oladapo Yeku, et al.
Published: (2020-09-01) -
Ospemifene for vulvar and vaginal atrophy: an overview
by: Santiago Palacios
Published: (2020-07-01) -
Cervical, vaginal and vulvar intraepithelial neoplasms
by: Mitrović-Jovanović Ana, et al.
Published: (2011-01-01)